Portal de Periódicos da CAPES

Diagnosis and Management of Infantile Hemangioma

2015; American Academy of Pediatrics; Volume: 136; Issue: 4 Linguagem: Inglês

10.1542/peds.2015-2485

1098-4275

David H. Darrow, Arin K. Greene, Anthony J. Mancini, Amy J. Nopper, Richard J. Antaya, Bernard A. Cohen, Beth A. Drolet, Aaron Fay, Steven J. Fishman, Sheila Fallon Friedlander, Fred Ghali, Kimberly A. Horii, Manish Patel, Denise W. Metry, Paula E. North, Teresa M. O, Jonathan A. Perkins, Michael L. Smith, Patricia Treadwell, Milton Waner, Albert C. Yan, Anna L. Bruckner, Kim Horii, Nanette B. Silverberg, Teresa S. Wright, Charles M. Bower, Christina Baldassari, G. Paul Digoy, Andrew J. Hotaling, Stacey L. Ishman, John E. McClay, Diego Preciado, Kristina W. Rosbe, Scott R. Schoem, Jeffrey S. Simons, Steven E. Sobol, David L. Walner, Peter J. Taub, Stephen B. Baker, Arin K. Greene, Timothy W. King, Donald R. Mackay, Delora L. Mount, Jordon Philip Steinberg, Mark M. Urata,

Tumors and Oncological Cases

Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors, they have the unique ability to involute after proliferation, often leading primary care providers to assume they will resolve without intervention or consequence. Unfortunately, a subset of IHs rapidly develop complications, resulting in pain, functional impairment, or permanent disfigurement. As a result, the primary clinician has the task of determining which lesions require early consultation with a specialist. Although several recent reviews have been published, this clinical report is the first based on input from individuals representing the many specialties involved in the treatment of IH. Its purpose is to update the pediatric community regarding recent discoveries in IH pathogenesis, treatment, and clinical associations and to provide a basis for clinical decision-making in the management of IH.